The DF/HCC Clinical Pharmacology Core provides investigators with the necessary expertise and resources to design and undertake pharmacokinetic (PK) studies in Phase I and II clinical trials, and preclinical investigations. These studies are essential to the development and evaluation of new drugs and combination regimens for cancer treatment. The core’s services facilitate the acquisition of PK data in a timely and cost-effective manner.
Clinical Trials, Consulting, and Management Services
ADME/DMPK Studies Services
MGH DF/HCC Clinical Pharmacology Core has not received any reviews.
MGH DF/HCC Clinical Pharmacology Core has not received any endorsements.